On May 24, the 2024 Pharmaceutical Industry Quality Control Technology Conference, co-hosted by Beijing Yaozhidian Information Technology Center and Beijing Zhongpei Kejian Information Technology Center, concluded successfully in Hefei. Hippocrates was invited to attend the conference. On the day of the event, Singerdi showcased its Aotai® OwlTrust® digital platform and supporting products and solutions at the exhibition booth, drawing extensive attention from numerous enterprises.

Staged to build a platform for academic exchange and information sharing among professionals engaged in pharmaceutical quality management and control, the conference aimed to drive sustainable innovation in pharmaceutical safety technologies across China. During the conference, a host of experts from the Center for Drug Evaluation of the National Medical Products Administration, national pharmaceutical inspectors and Anhui Institute for Food and Drug Control delivered keynote speeches and shared practical experience covering a wide range of topics, including key procedures and focuses of pharmaceutical registration inspections, critical points for marketing authorization holders in managing entrusted production, characteristics and case studies of exploratory pharmaceutical research in the new era, and microbial laboratory management. Packed with valuable industry insights, the event attracted hundreds of industry practitioners from all over the country.

Exhibitors displayed cutting-edge instruments and efficient solutions at the exhibition area, drawing crowds of attendees for consultation.

Event Recap

Hippocrates presented its self-developed Aotai® OwlTrust® digital platform and industry-leading digital solutions at the conference, featuring its core product portfolio including document management, training management, quality management, pharmacovigilance and electronic contract systems, alongside tailored solutions such as the entrusted production quality management collaboration system Aomai™ (OWL MAH™) and comprehensive quality compliance solutions. Professional technical engineers were stationed at the booth to provide one-on-one consultations and live product demonstrations. The Hippocrates booth became a popular destination for attendees eager to learn about the company’s technologies and product offerings, sparking in-depth exchanges.

China’s pharmaceutical industry is currently undergoing a critical transformation period filled with both opportunities and challenges. Digital technologies will continue to empower enterprises and unlock greater growth potential. Aligning closely with evolving industry trends, Hippocrates will keep upgrading its digital technologies and service capabilities, delivering premium industry-specific digital solutions for life science and healthcare enterprises to help the life health industry unlock greater value.